Healthcare provider profile · identity verified

Susan Linn Johnson, CFNP

Nurse Practitioner · WEST BRANCH, MI · NPI 1912949801

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	657	213
Levothyroxine Sodium	Levothyroxine Sodium	432	110
Lisinopril	Lisinopril	338	104
Losartan Potassium	Losartan Potassium	313	82
Omeprazole	Omeprazole	313	103
Amlodipine Besylate	Amlodipine Besylate	245	76
Metformin Hcl	Metformin Hcl	231	74
Simvastatin	Simvastatin	175	49
Metoprolol Tartrate	Metoprolol Tartrate	164	52
Hydrochlorothiazide	Hydrochlorothiazide	163	49
Eliquis	Apixaban	159	37
Potassium Chloride	Potassium Chloride	159	51
Metoprolol Succinate	Metoprolol Succinate	153	43
Furosemide	Furosemide	145	47
Rosuvastatin Calcium	Rosuvastatin Calcium	131	41
Cefdinir	Cefdinir	114	108
Glimepiride	Glimepiride	114	37
Pantoprazole Sodium	Pantoprazole Sodium	105	32
Meloxicam	Meloxicam	99	38
Tamsulosin Hcl	Tamsulosin Hcl	92	34
Escitalopram Oxalate	Escitalopram Oxalate	89	28
Clopidogrel	Clopidogrel Bisulfate	85	17
Carvedilol	Carvedilol	82	29
Pravastatin Sodium	Pravastatin Sodium	82	22
Albuterol Sulfate Hfa	Albuterol Sulfate	81	46
Trazodone Hcl	Trazodone Hcl	81	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	77	21
Duloxetine Hcl	Duloxetine Hcl	74	25
Gabapentin	Gabapentin	74	19
Alendronate Sodium	Alendronate Sodium	70	23
Atenolol	Atenolol	68	19
Paroxetine Hcl	Paroxetine Hcl	65	20
Ezetimibe	Ezetimibe	63	21
Methylprednisolone	Methylprednisolone	60	58
Sertraline Hcl	Sertraline Hcl	60	19
Fluticasone Propionate	Fluticasone Propionate	58	25
Quetiapine Fumarate	Quetiapine Fumarate	56	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	52	16
Citalopram Hbr	Citalopram Hydrobromide	51	suppressed
Donepezil Hcl	Donepezil Hcl	51	suppressed
Montelukast Sodium	Montelukast Sodium	51	19
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	50	18
Xarelto	Rivaroxaban	47	12
Januvia	Sitagliptin Phosphate	45	11
Allopurinol	Allopurinol	44	15
Spironolactone	Spironolactone	41	14
Bupropion Xl	Bupropion Hcl	40	13
Ozempic	Semaglutide	40	suppressed
Symbicort	Budesonide/Formoterol Fumarate	39	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	39	13
Enalapril Maleate	Enalapril Maleate	38	11
Doxycycline Hyclate	Doxycycline Hyclate	35	30
Isosorbide Mononitrate Er	Isosorbide Mononitrate	35	11
Lantus	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Farxiga	Dapagliflozin Propanediol	32	14
Fenofibrate	Fenofibrate Nanocrystallized	31	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	30	11
Nifedipine Er	Nifedipine	30	suppressed
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Alprazolam	Alprazolam	27	suppressed
Buspirone Hcl	Buspirone Hcl	27	suppressed
Levemir Flexpen	Insulin Detemir	27	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Tramadol Hcl	Tramadol Hcl	27	suppressed
Warfarin Sodium	Warfarin Sodium	27	11
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	26	20
Ibuprofen	Ibuprofen	26	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Ramipril	Ramipril	22	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Lorazepam	Lorazepam	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	16
Ondansetron Hcl	Ondansetron Hcl	19	13
Ibandronate Sodium	Ibandronate Sodium	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	suppressed
Flecainide Acetate	Flecainide Acetate	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Bumetanide	Bumetanide	16	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Digoxin	Digoxin	16	suppressed
Dilt-Xr	Diltiazem Hcl	16	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Glyburide	Glyburide	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Azithromycin	Azithromycin	15	15
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Famotidine	Famotidine	15	suppressed
Glipizide	Glipizide	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	13
Finasteride	Finasteride	14	suppressed
Fluconazole	Fluconazole	14	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Jardiance	Empagliflozin	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Ammonium Lactate	Ammonium Lactate	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Febuxostat	Febuxostat	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Nystatin	Nystatin	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Galantamine Er	Galantamine Hbr	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error